Specifica Inc is a Santa Fe-based company specializing in the creation of exceptional Antibody Libraries. Their visionary antibody technologies and deal structures empower clients to generate antibody drugs against any target, with antibodies selected from their libraries exhibiting high affinities and developability properties comparable to or better than clinical antibodies on the market.
With a focus on diversity and developability, Specifica's Generation 3 Platform offers exclusive assets, full platform transfer, and the ability to collaborate and customize library designs. Their integrated antibody discovery platform, including next generation sequencing and machine learning, enables the generation of diverse, high affinity, drug-like, and developable antibodies. Their straightforward terms and tailored structures ensure a seamless partnership experience.
Generated from the website